For black worshipers in New Orleans, religious beliefs can affect health.

Published Date: 02 Mar 2023

Members of the New Orleans Black Church who believe religion plays an important role in health may eat more fruits and vegetables, be physically active, and be more likely to ask more health questions. .

Read Full News

Latest News

What Is the Celebrity Effect? When Awareness Drives Action

From cancer to Parkinson's disease, public figures shape health perceptions in ways that few traditional awareness campaigns can achieve.

Exosomes Move Into the Regenerative Medicine Spotlight

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin rejuvenation, alopecia, and wound healing.

Ultraprocessing May Not Be ‘Inherently Harmful’

Randomized controlled trials provide ‘weak support’ for the idea that ultraprocessed foods are ‘inherently harmful’ simply because they are ultraprocessed.

Early Semaglutide After Bariatric Surgery Improves Outcomes

A prospective study finds that semaglutide initiated 1 month after sleeve gastrectomy is associated with greater weight loss at 1 year than surgery alone.

DAPT for 1 Month Tied to Lower Risk for NACE

Dual antiplatelet therapy for 1 month is tied to a lower risk for NACE after stent placement, with a greater drop in bleeding than increase in the risk for MI seen with longer use.

Groups Urge Delay to NHS Workforce Plan

NHS leaders have called for a pause to the workforce plan, warning it underestimates staffing needs and overstates AI benefits.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Latest News

From cancer to Parkinson's disease, public figures shape health perceptions in ways that few traditional awareness campaigns can achieve.

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin rejuvenation, alopecia, and wound healing.

Randomized controlled trials provide ‘weak support’ for the idea that ultraprocessed foods are ‘inherently harmful’ simply because they are ultraprocessed.

A prospective study finds that semaglutide initiated 1 month after sleeve gastrectomy is associated with greater weight loss at 1 year than surgery alone.

Dual antiplatelet therapy for 1 month is tied to a lower risk for NACE after stent placement, with a greater drop in bleeding than increase in the risk for MI seen with longer use.

NHS leaders have called for a pause to the workforce plan, warning it underestimates staffing needs and overstates AI benefits.

News All Time

Rivaroxaban Flops for Prevention in Advanced CKD

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting prevention seen in other high-risk populations.

Advance Directives May Reduce Unnecessary End-of-Life Care

Older adults close to death often receive unnecessary end-of-life medical treatments in hospitals.

Obesity Stigma: Is Art History the Fix?

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat patients with more compassion, a researcher proposes.

Retatrutide Data Show Dramatic Weight Loss, Other Benefits

Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Digoxin Shows Signs of a Heart Failure Revival

New trial data from the Heart Failure 2026 conference suggest that low-dose digoxin may reduce worsening HF events, reigniting debate over digitalis therapy.

Solutions Emerging for Post-GLP-1 Weight Regain

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients maintain weight loss.

FDA Neurology Roundup: May 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Is At-Home, Extended-Release Ketamine Coming to Market Soon?

A new take-home tablet is in development, but will the features that make it attractive blunt the experience that could be part of ketamine’s therapeutic value?

Mortality Predictors in Vasculitis With Kidney Involvement

Among patients with ANCA-positive vasculitis and severe kidney involvement, older age and low serum albumin levels at diagnosis are independent predictors of long-term mortality.

Hidden Heart Disease Found in At-Risk Communities

Silent MIs and undiagnosed heart disease were common in deprived and ethnically diverse communities — found via primary care and social media.

Teen Fitness Tied to Early AF Risk, Later CVD Benefit

In men, high adolescent cardiorespiratory fitness is linked to a small excess risk for atrial fibrillation in early adulthood but larger reductions in the risk for other cardiovascular events later on.

Weight Loss May Not Ease Symptoms of AF in Older Patients

A low-calorie diet program may facilitate significant weight loss among older patients with persistent atrial fibrillation, but this may not translate into reduced severity of disease symptoms.

Zurich Heart Surgery Scandal: Device Safety Alert

An independent inquiry links roughly 70 excess deaths at Zurich’s university heart clinic (2016-2020); prosecutors now probe valve-implant use, raising device-safety concerns.

Women Underreferred for Advanced Heart Failure Care

Women in the UK and Ireland account for just 1 in 3 advanced heart failure referrals, despite similar disease burden, an audit finds.

Robotic Mitral Valve Surgery Shows Durable Results

Robotic mitral valve repair achieved excellent long-term durability and shortened ICU and hospital stays compared with endoscopic surgery.

Drug Interactions Common With DOACs in AF

Drug-drug interactions with direct oral anticoagulants are common in Belgian primary care, affecting nearly 1 in 4 patients with non-valvular atrial fibrillation over a year.